Selected research
Market Analysis & Forecast
Global Nuclear Medicine Diagnostic Equipment Market Analysis and Forecast 2026-2032
Market perspective
The global Nuclear Medicine Diagnostic Equipment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Nuclear Medicine Diagnostic Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Nuclear Medicine Diagnostic Equipment include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compañía Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Nuclear Medicine Diagnostic Equipment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Nuclear Medicine Diagnostic Equipment, also provides the sales of main regions and countries. Of the upcoming market potential for Nuclear Medicine Diagnostic Equipment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nuclear Medicine Diagnostic Equipment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nuclear Medicine Diagnostic Equipment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nuclear Medicine Diagnostic Equipment sales, projected growth trends, production technology, application and end-user industry.
Nuclear Medicine Diagnostic Equipment Segment by Company
GE HealthCare
Siemens Healthineers
CMR Naviscan
Compañía Mexicana
DDD-Diagnostic
Digirad
Mediso Medical Imaging Systems
Philips
Positron
SurgicEye
TeraRecon
Toshiba
Top Grade Healthcare
Neusoft Group
United Imaging
MinFound Medical
SinoUnion Healthcare
Nuclear Medicine Diagnostic Equipment Segment by Type
PET
SPECT
Nuclear Medicine Diagnostic Equipment Segment by Application
Tumor Imaging
Endocrine System Imaging
Urinary System Imaging
Bone Marrow Imaging
Others
Nuclear Medicine Diagnostic Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nuclear Medicine Diagnostic Equipment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine Diagnostic Equipment sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PET
- SPECT
Applications
- Tumor Imaging
- Endocrine System Imaging
- Urinary System Imaging
- Bone Marrow Imaging
- Others
Companies covered
- GE HealthCare
- Siemens Healthineers
- CMR Naviscan
- Compañía Mexicana
- DDD-Diagnostic
- Digirad
- Mediso Medical Imaging Systems
- Philips
- Positron
- SurgicEye
- TeraRecon
- Toshiba
- Top Grade Healthcare
- Neusoft Group
- United Imaging
- MinFound Medical
- SinoUnion Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Nuclear Medicine Diagnostic Equipment Market by Type
- 1.2.1 Global Nuclear Medicine Diagnostic Equipment Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 PET
- 1.2.3 SPECT
- 1.3 Nuclear Medicine Diagnostic Equipment Market by Application
- 1.3.1 Global Nuclear Medicine Diagnostic Equipment Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Tumor Imaging
- 1.3.3 Endocrine System Imaging
- 1.3.4 Urinary System Imaging
- 1.3.5 Bone Marrow Imaging
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Nuclear Medicine Diagnostic Equipment Market Dynamics
- 2.1 Nuclear Medicine Diagnostic Equipment Industry Trends
- 2.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
- 2.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
- 2.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Nuclear Medicine Diagnostic Equipment Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Region
- 3.2.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026)
- 3.2.3 Global Nuclear Medicine Diagnostic Equipment Revenue by Region (2027-2032)
- 3.2.4 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2021-2032)
- 3.3 Global Nuclear Medicine Diagnostic Equipment Sales Estimates and Forecasts 2021-2032
- 3.4 Global Nuclear Medicine Diagnostic Equipment Sales by Region
- 3.4.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026)
- 3.4.3 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2027-2032)
- 3.4.4 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Manufacturers
- 4.1.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Nuclear Medicine Diagnostic Equipment Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Nuclear Medicine Diagnostic Equipment Sales by Manufacturers
- 4.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Manufacturers (2021-2026)
- 4.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Nuclear Medicine Diagnostic Equipment Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Nuclear Medicine Diagnostic Equipment Sales Price by Manufacturers (2021-2026)
- 4.4 Global Nuclear Medicine Diagnostic Equipment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Nuclear Medicine Diagnostic Equipment Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Nuclear Medicine Diagnostic Equipment Manufacturers, Product Type & Application
- 4.7 Global Nuclear Medicine Diagnostic Equipment Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Nuclear Medicine Diagnostic Equipment Market CR5 and HHI
- 4.8.2 2025 Nuclear Medicine Diagnostic Equipment Tier 1, Tier 2, and Tier 3
5 Nuclear Medicine Diagnostic Equipment Market by Type
- 5.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Type
- 5.1.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2032)
- 5.2 Global Nuclear Medicine Diagnostic Equipment Sales by Type
- 5.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2032)
- 5.3 Global Nuclear Medicine Diagnostic Equipment Price by Type
6 Nuclear Medicine Diagnostic Equipment Market by Application
- 6.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Application
- 6.1.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2032)
- 6.2 Global Nuclear Medicine Diagnostic Equipment Sales by Application
- 6.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2032)
- 6.3 Global Nuclear Medicine Diagnostic Equipment Price by Application
7 Company Profiles
- 7.1 GE HealthCare
- 7.1.1 GE HealthCare Company Information
- 7.1.2 GE HealthCare Business Overview
- 7.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.1.5 GE HealthCare Recent Developments
- 7.2 Siemens Healthineers
- 7.2.1 Siemens Healthineers Company Information
- 7.2.2 Siemens Healthineers Business Overview
- 7.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.2.5 Siemens Healthineers Recent Developments
- 7.3 CMR Naviscan
- 7.3.1 CMR Naviscan Company Information
- 7.3.2 CMR Naviscan Business Overview
- 7.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.3.5 CMR Naviscan Recent Developments
- 7.4 Compañía Mexicana
- 7.4.1 Compañía Mexicana Company Information
- 7.4.2 Compañía Mexicana Business Overview
- 7.4.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.4.5 Compañía Mexicana Recent Developments
- 7.5 DDD-Diagnostic
- 7.5.1 DDD-Diagnostic Company Information
- 7.5.2 DDD-Diagnostic Business Overview
- 7.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.5.5 DDD-Diagnostic Recent Developments
- 7.6 Digirad
- 7.6.1 Digirad Company Information
- 7.6.2 Digirad Business Overview
- 7.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.6.5 Digirad Recent Developments
- 7.7 Mediso Medical Imaging Systems
- 7.7.1 Mediso Medical Imaging Systems Company Information
- 7.7.2 Mediso Medical Imaging Systems Business Overview
- 7.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.7.5 Mediso Medical Imaging Systems Recent Developments
- 7.8 Philips
- 7.8.1 Philips Company Information
- 7.8.2 Philips Business Overview
- 7.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.8.5 Philips Recent Developments
- 7.9 Positron
- 7.9.1 Positron Company Information
- 7.9.2 Positron Business Overview
- 7.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.9.5 Positron Recent Developments
- 7.10 SurgicEye
- 7.10.1 SurgicEye Company Information
- 7.10.2 SurgicEye Business Overview
- 7.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.10.5 SurgicEye Recent Developments
- 7.11 TeraRecon
- 7.11.1 TeraRecon Company Information
- 7.11.2 TeraRecon Business Overview
- 7.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.11.5 TeraRecon Recent Developments
- 7.12 Toshiba
- 7.12.1 Toshiba Company Information
- 7.12.2 Toshiba Business Overview
- 7.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.12.5 Toshiba Recent Developments
- 7.13 Top Grade Healthcare
- 7.13.1 Top Grade Healthcare Company Information
- 7.13.2 Top Grade Healthcare Business Overview
- 7.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.13.5 Top Grade Healthcare Recent Developments
- 7.14 Neusoft Group
- 7.14.1 Neusoft Group Company Information
- 7.14.2 Neusoft Group Business Overview
- 7.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.14.5 Neusoft Group Recent Developments
- 7.15 United Imaging
- 7.15.1 United Imaging Company Information
- 7.15.2 United Imaging Business Overview
- 7.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.15.5 United Imaging Recent Developments
- 7.16 MinFound Medical
- 7.16.1 MinFound Medical Company Information
- 7.16.2 MinFound Medical Business Overview
- 7.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.16.5 MinFound Medical Recent Developments
- 7.17 SinoUnion Healthcare
- 7.17.1 SinoUnion Healthcare Company Information
- 7.17.2 SinoUnion Healthcare Business Overview
- 7.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
- 7.17.5 SinoUnion Healthcare Recent Developments
8 North America
- 8.1 North America Nuclear Medicine Diagnostic Equipment Market Size by Type
- 8.1.1 North America Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
- 8.1.2 North America Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
- 8.1.3 North America Nuclear Medicine Diagnostic Equipment Price by Type (2021-2032)
- 8.2 North America Nuclear Medicine Diagnostic Equipment Market Size by Application
- 8.2.1 North America Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
- 8.2.2 North America Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
- 8.2.3 North America Nuclear Medicine Diagnostic Equipment Price by Application (2021-2032)
- 8.3 North America Nuclear Medicine Diagnostic Equipment Market Size by Country
- 8.3.1 North America Nuclear Medicine Diagnostic Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Nuclear Medicine Diagnostic Equipment Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Nuclear Medicine Diagnostic Equipment Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Nuclear Medicine Diagnostic Equipment Market Size by Type
- 9.1.1 Europe Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
- 9.1.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
- 9.1.3 Europe Nuclear Medicine Diagnostic Equipment Price by Type (2021-2032)
- 9.2 Europe Nuclear Medicine Diagnostic Equipment Market Size by Application
- 9.2.1 Europe Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
- 9.2.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
- 9.2.3 Europe Nuclear Medicine Diagnostic Equipment Price by Application (2021-2032)
- 9.3 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country
- 9.3.1 Europe Nuclear Medicine Diagnostic Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Nuclear Medicine Diagnostic Equipment Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Nuclear Medicine Diagnostic Equipment Market Size by Type
- 10.1.1 China Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
- 10.1.2 China Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
- 10.1.3 China Nuclear Medicine Diagnostic Equipment Price by Type (2021-2032)
- 10.2 China Nuclear Medicine Diagnostic Equipment Market Size by Application
- 10.2.1 China Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
- 10.2.2 China Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
- 10.2.3 China Nuclear Medicine Diagnostic Equipment Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Nuclear Medicine Diagnostic Equipment Market Size by Type
- 11.1.1 Asia Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
- 11.1.2 Asia Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
- 11.1.3 Asia Nuclear Medicine Diagnostic Equipment Price by Type (2021-2032)
- 11.2 Asia Nuclear Medicine Diagnostic Equipment Market Size by Application
- 11.2.1 Asia Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
- 11.2.2 Asia Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
- 11.2.3 Asia Nuclear Medicine Diagnostic Equipment Price by Application (2021-2032)
- 11.3 Asia Nuclear Medicine Diagnostic Equipment Market Size by Country
- 11.3.1 Asia Nuclear Medicine Diagnostic Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Nuclear Medicine Diagnostic Equipment Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Nuclear Medicine Diagnostic Equipment Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Nuclear Medicine Diagnostic Equipment Market Size by Type
- 12.1.1 SAMEA Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2032)
- 12.1.2 SAMEA Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2032)
- 12.1.3 SAMEA Nuclear Medicine Diagnostic Equipment Price by Type (2021-2032)
- 12.2 SAMEA Nuclear Medicine Diagnostic Equipment Market Size by Application
- 12.2.1 SAMEA Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2032)
- 12.2.2 SAMEA Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2032)
- 12.2.3 SAMEA Nuclear Medicine Diagnostic Equipment Price by Application (2021-2032)
- 12.3 SAMEA Nuclear Medicine Diagnostic Equipment Market Size by Country
- 12.3.1 SAMEA Nuclear Medicine Diagnostic Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Nuclear Medicine Diagnostic Equipment Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Nuclear Medicine Diagnostic Equipment Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
- 13.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Nuclear Medicine Diagnostic Equipment Production Mode & Process
- 13.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Nuclear Medicine Diagnostic Equipment Distributors
- 13.2.3 Nuclear Medicine Diagnostic Equipment Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst